These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34462268)

  • 1. Elucidation of Metabolic and Disposition Pathways for Maribavir in Nonhuman Primates through Mass Balance and Semi-Physiologically Based Modeling Approaches.
    Sun K; Welty D
    Drug Metab Dispos; 2021 Nov; 49(11):1025-1037. PubMed ID: 34462268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey.
    Shou M; Lu W; Kari PH; Xiang C; Liang Y; Lu P; Cui D; Emary WB; Michel KB; Adelsberger JK; Brunner JE; Rodrigues AD
    Eur J Pharm Sci; 2005 Oct; 26(2):151-61. PubMed ID: 16085400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterohepatic circulation of glucuronide metabolites of drugs in dog.
    Zhou X; Cassidy KC; Hudson L; Mohutsky MA; Sawada GA; Hao J
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00502. PubMed ID: 31333846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers.
    Song IH; Ilic K; Murphy J; Lasseter K; Martin P
    J Clin Pharmacol; 2020 Jan; 60(1):96-106. PubMed ID: 31385617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
    Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
    Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication.
    Koszalka GW; Johnson NW; Good SS; Boyd L; Chamberlain SC; Townsend LB; Drach JC; Biron KK
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2373-80. PubMed ID: 12121907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment.
    Swan SK; Smith WB; Marbury TC; Schumacher M; Dougherty C; Mico BA; Villano SA
    J Clin Pharmacol; 2007 Feb; 47(2):209-17. PubMed ID: 17244772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of an alpha4beta2 nicotinic acetylcholine receptor partial agonist in sprague-dawley rats and the dispositional characterization of its N-carbamoyl glucuronide metabolite.
    Shaffer CL; Ryder TF; Venkatakrishnan K; Henne IK; O'Connell TN
    Drug Metab Dispos; 2009 Jul; 37(7):1480-9. PubMed ID: 19339375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263.
    Drugs R D; 2007; 8(3):188-92. PubMed ID: 17472414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation as a major metabolic clearance pathway of 14c-labeled muraglitazar in humans: metabolic profiles in subjects with or without bile collection.
    Wang L; Zhang D; Swaminathan A; Xue Y; Cheng PT; Wu S; Mosqueda-Garcia R; Aurang C; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 Mar; 34(3):427-39. PubMed ID: 16381667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence.
    Liu H; Sun H; Lu D; Zhang Y; Zhang X; Ma Z; Wu B
    Xenobiotica; 2014 Aug; 44(8):696-707. PubMed ID: 24555821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ketoconazole on the pharmacokinetics of maribavir in healthy adults.
    Goldwater DR; Dougherty C; Schumacher M; Villano SA
    Antimicrob Agents Chemother; 2008 May; 52(5):1794-8. PubMed ID: 18316526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, pharmacokinetic study of oral maribavir with tacrolimus in stable renal transplant recipients.
    Pescovitz MD; Bloom R; Pirsch J; Johnson J; Gelone S; Villano SA
    Am J Transplant; 2009 Oct; 9(10):2324-30. PubMed ID: 19663892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of canagliflozin in mice, rats, dogs, and humans.
    Mamidi RN; Cuyckens F; Chen J; Scheers E; Kalamaridis D; Lin R; Silva J; Sha S; Evans DC; Kelley MF; Devineni D; Johnson MD; Lim HK
    Drug Metab Dispos; 2014 May; 42(5):903-16. PubMed ID: 24568888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and Disposition of the Novel Oral Factor XIa Inhibitor Asundexian in Rats and in Humans.
    Piel I; Engelen A; Lang D; Schulz SI; Gerisch M; Brase C; Janssen W; Fiebig L; Heitmeier S; Kanefendt F
    Eur J Drug Metab Pharmacokinet; 2023 Jul; 48(4):411-425. PubMed ID: 37365440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites.
    Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG
    Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
    Prakash C; Cui D
    Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and disposition of [14C]brivanib alaninate after oral administration to rats, monkeys, and humans.
    Gong J; Gan J; Caceres-Cortes J; Christopher LJ; Arora V; Masson E; Williams D; Pursley J; Allentoff A; Lago M; Tran SB; Iyer RA
    Drug Metab Dispos; 2011 May; 39(5):891-903. PubMed ID: 21289073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.